Top Markets
Coin of the day
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
Rangering i aksjer #14216
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading... Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
Aksjekurs
$12.33
Sist synkronisert: 2026-08-31
Markedsverdi
$428.31M
Endring (1 dag)
0.49%
Endring (1 år)
39.01%
Land
US
Handel Fennec Pharmaceuticals Inc. (FENC)

Kategori

Historikk for aksjesplitt for Fennec Pharmaceuticals Inc. (FENC)
Aksjen Fennec Pharmaceuticals Inc. (symbol: FENC) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Sep 01, 2026.
Én FENC-aksje kjøpt før Sep 01, 2026 tilsvarer i dag 0 FENC-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH